And the boards are watching: pharmacy, medical, and nursing regulators jointly flagged IV hydration clinic risks, emphasizing that a licensed practitioner must evaluate the patient and order the therapy
NICE NG28 GLP-1 RA or tirzepatide should be added as further therapy for T2D with obesity after at least 3 months of initial therapy if glycemic targets are not met
The first half of 2025 has confirmed a seismic shift in the pharmaceutical landscape: GLP-1 receptor agonists a class of new drug therapies for diabetes and obesity now dominate global sales charts
Wound-Model Findings (preclinical): Animal wound-chamber research has linked local exposure to increased connective-tissue components such as collagen and glycosaminoglycans
Giving yourself B12 injections at home is easier and more convenient than having your doctor do it every time, but doing the first injection can be a little unnerving for most folks
If you cant keep fluids in due to severe diarrhea (which is rare with GLP-1, but just in case), seek medical attention